“Megan’s leadership has been a significant driver of Praxis’s success to date,” said Mr. Souza. “As COO, she is uniquely positioned to guide Praxis through its next phase, driving disciplined ...

PrimoChill Praxis WetBench. Confirmed AiO's that work on the WetBench: - nzxt Kraken X52 - nzxt Kraken X62 AiO's that do not work on the WetBench: - Corsair H100i - Fractal Design Celsius S24 "Like" ...

ETS's Praxis program, the leading provider of teacher licensure assessments, welcomes the adoption of Praxis as an approved ...

Praxis Precision Medicines remains a Hold as valuation now reflects high expectations for ulixacaltamide and its epilepsy ...

The latest announcement is out from Praxis Precision Medicines ( ($PRAX) ). On December 29, 2025, Praxis Precision Medicines, Inc. reported that ...

If you are wondering whether Praxis Precision Medicines is still worth a look after its huge run up, or if the best days are already priced in, you are in the right place to dig into what the market ...

Praxis Precision Medicines, Inc. (PRAX) stock is soaring in trading today, up 35% at time of writing, with shares reaching a value of $260, their highest value since the beginning of 2022. Current ...

Praxis Precision Medicines Inc. (NASDAQ: PRAX) shares surged 24.81% in pre-market trading on Friday, climbing to $237.10. Check out the current price of PRAX stock here. PRAX closed Thursday's regular ...

Culper Research report argues that the data underpinning its essential tremor program cannot withstand regulatory scrutiny. According to the short report, Praxis engineered its October 2025 results ...

Investing.com -- Praxis Precision Medicines (NASDAQ:PRAX) stock dropped 4% on Thursday following the release of a critical short report from Culper Research questioning the company’s Phase 3 trial ...

The Praxis® tests are a series of exams required by the Kentucky Education Professional Standards Board for individuals entering an educator preparation program and seeking certification to teach.

Shares of biopharmaceutical company Praxis Precision Medicines Inc. soared Thursday, boosted by the successful trial of a new drug to treat movement disorders. The drug, ulixacaltamide, targets ...